SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306) (TNXP) — Dec 18, 2013

Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306)
Date: Dec. 18, 2013 · CIK: 0001430306 · Accession: 0001144204-13-067819

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-186223, 333-188547, 333-192541, 333-192551

Date
December 18, 2013
Author
/s/ SETH LEDERMAN
Form
CORRESP
Company
Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306)

Letter

Tonix Pharmaceuticals Holding Corp.

509 Madison Avenue, Suite 306

New York, New York 10022

December 18, 2013

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

Attn: Erin Wilson, Esq.

Division of Corporation Finance

Re: Tonix Pharmaceuticals Holding Corp.

Registration Statement on Form S-3

Filed November 26, 2013

File No. 333-192551

Ladies and Gentlemen:

The following responses address the oral comment of the reviewing staff of the Commission pursuant to a telephone conversation by and between Erin Wilson of the Commission and James M. Turner of Sichenzia Ross Friedman Ference LLP relating to the Registration Statement on Form S-3 filed on November 26, 2013 (the "Registration Statement") by Tonix Pharmaceuticals Holding Corp. (the “Company”).

1. Please revise the disclosure on the front cover page of the prospectus in accordance with Instruction 7 to Form S-3 in order to provide the calculation of the aggregate market value of the Company’s outstanding common stock and the amount of all securities offered during the prior 12 calendar months.

Response:

The Company will revise the disclosure on the front cover page of the prospectus in accordance with Instruction 7 to Form S-3 in order to provide the calculation of the aggregate market value of the Company’s outstanding common stock and the amount of all securities offered during the prior 12 calendar months.

2. In reviewing footnote 5 to the Calculation of Fee Registration Fee, we do not believe that the Company is entitled to an offset of the fee from the prior registration statement indicated. Please provide evidence that the Company is not required to deposit additional funds in its SEC account to cover such shortfall after the offset is removed.

Response:

After a review of the Company’s account with the SEC and the fees incurred in connection with registration statements filed during 2013, the Company believes that the offset is correct and that the Company should have a credit of $533.54. Exhibit A sets forth a chronology of transactions since January 1, 2013 to support this conclusion.

After reviewing the transaction history from the Company’s transfer agent, we have determined that the problems started in June 2013 when it appears that the S-1/A filing made on June 20, 2013 doesn’t reflect that there should have been another $500.86 cash filing fee incurred. There was a total fee of $3,839.93, of which $3,339.07 was previously paid. Then moving forward, there were fees incurred of $2,203.13 in August 2013, which I believe the SEC calculated as the $500.86 which wasn’t incurred on June 20, 2013 plus the $1,702.27 that was originally due, however, that $1,702.27 was paid on May 10, 2013. So, Tonix got charged $1,702.27 twice by the SEC.

We trust that the foregoing appropriately addresses the issues raised by your recent Letter of Comment. Thank you in advance for your prompt review and assistance.

Very truly yours,
/s/ SETH LEDERMAN

Show Raw Text
CORRESP
1
filename1.htm

Tonix Pharmaceuticals Holding Corp.

509 Madison Avenue, Suite 306

New York, New York 10022

December 18, 2013

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

 Attn: Erin Wilson, Esq.

Division of Corporation Finance

 Re: Tonix Pharmaceuticals Holding Corp.

Registration Statement on
Form S-3

Filed November 26, 2013

File
No. 333-192551

Ladies and Gentlemen:

The following responses
address the oral comment of the reviewing staff of the Commission pursuant to a telephone conversation by and between Erin Wilson
of the Commission and James M. Turner of Sichenzia Ross Friedman Ference LLP relating to the Registration Statement on Form S-3
filed on November 26, 2013 (the "Registration Statement") by Tonix Pharmaceuticals Holding Corp. (the “Company”).

 1. Please revise the disclosure on the front cover page of the prospectus in accordance with Instruction
7 to Form S-3 in order to provide the calculation of the aggregate market value of the Company’s outstanding common stock
and the amount of all securities offered during the prior 12 calendar months.

Response:

The Company will revise the disclosure
on the front cover page of the prospectus in accordance with Instruction 7 to Form S-3 in order to provide the calculation of the
aggregate market value of the Company’s outstanding common stock and the amount of all securities offered during the prior
12 calendar months.

 2. In reviewing footnote 5 to the Calculation of Fee Registration Fee, we do not believe that the
Company is entitled to an offset of the fee from the prior registration statement indicated. Please provide evidence that the Company
is not required to deposit additional funds in its SEC account to cover such shortfall after the offset is removed.

Response:

After a review of the Company’s
account with the SEC and the fees incurred in connection with registration statements filed during 2013, the Company believes that
the offset is correct and that the Company should have a credit of $533.54. Exhibit A sets forth a chronology of transactions
since January 1, 2013 to support this conclusion.

After reviewing the transaction
history from the Company’s transfer agent, we have determined that the problems started in June 2013 when it appears that
the S-1/A filing made on June 20, 2013 doesn’t reflect that there should have been another $500.86 cash filing fee incurred.
There was a total fee of $3,839.93, of which $3,339.07 was previously paid.  Then moving forward, there were fees incurred
of $2,203.13 in August 2013, which I believe the SEC calculated as the $500.86 which wasn’t incurred on June 20, 2013 plus
the $1,702.27 that was originally due, however, that $1,702.27 was paid on May 10, 2013.  So, Tonix got charged $1,702.27
twice by the SEC.

We trust that the foregoing
appropriately addresses the issues raised by your recent Letter of Comment. Thank you in advance for your prompt review and assistance.

Very truly yours,

/s/ SETH LEDERMAN

Seth Lederman

Chief Executive Officer

 Cc: Marc J. Ross, Esq.

James M. Turner, Esq.

EXHIBIT A

    Date
    Credit (Debit)
    Explanation

    January 1, 2013
    $1,351.45
    Cash available in the Company’s SEC account

    January 25, 2013
    ($1,335.98)
    Filing fee for S-1 registration statement filed on January 25, 2013 (333-186223)

    January 25, 2013
    $15.47
    Cash available in the Company’s SEC account

    May 10, 2013
    1,800.00
    Cash deposit by the Company

    May 10, 2013
    $1,815.47
    Cash available in the Company’s SEC account

    May 10, 2013
    ($1,702.27)
    Filing fee for S-1 registration statement filed on May 10, 2013 (333-188547)

    May 10, 2013
    $113.20
    Cash available in the Company’s SEC account

    June 5, 2013
    2,000.00
    Cash deposit by the Company

    June 5, 2013
    $2,113.20
    Cash available in the Company’s SEC account

    June 6, 2013
    ($1,636.80)
    Filing fee for S-1/A registration statement filed on June 6, 2013 (333-186223)[1]

    June 6, 2013
    $476.40
    Cash available in the Company’s SEC account

    June 20, 2013
    ($500.86)
    Filing fee for S-1/A registration statement filed on June 20, 2013 (333-188547)[2]

    June 20, 2013
    ($24.46)
    Cash owed to the SEC account

    June 24, 2013
    500.00
    Cash deposit by the Company

    June 24, 2013
    $475.54
    Cash available in the Company’s SEC account

    November 22, 2013
    6,500.00
    Cash deposit by the Company

    November 22, 2013
    $6,975.54
    Cash available in the Company’s SEC account

    November 26, 2013
    ($6,440.00)
    Filing fee for S-3 registration statement filed on November 26, 2013 (333-192541)

    November 26, 2013
    $535.54
    Cash available in the Company’s SEC account

[1]
This amendment was filed on the wrong SEC file number and was withdrawn on June 20, 2013

[2]
The total amount of the registration fee on this filing was $3,839.93, of which $1,702.27 was paid on the initial filing on May
10, 2013, $1,636.80 was an offset from the June 6, 2013 amendment that was filed and withdrawn, and $500.86 was new fees owed on
that date.

    A-1